Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Case Reports
. 1992;83(2):113-9.
doi: 10.1007/BF00308470.

Clinicopathologic correlation and pathogenesis of ocular and central nervous system manifestations in Hallervorden-Spatz syndrome

Affiliations
Case Reports

Clinicopathologic correlation and pathogenesis of ocular and central nervous system manifestations in Hallervorden-Spatz syndrome

R C Tripathi et al. Acta Neuropathol. 1992.

Abstract

We have correlated the clinical and histopathologic features of the eyes and central nervous system in a patient with Hallervorden-Spatz syndrome who died at age 11 years. The main ocular findings included degeneration of photoreceptors, marked thinning of the outer nuclear and outer plexiform layers, retinal gliosis, narrowing and obliteration of blood vessels with a perivascular cuffing of pigment cells, and degenerative changes in the retinal pigment epithelial cells with accumulation of melanolipofuscin. The positive findings in the brain included a symmetrical, partially destructive lesion of the globus pallidus, especially in its internal fibers and neurons; in addition, we noted gliosis, widely disseminated axonal spheroidal bodies, which were most numerous in the globus pallidus and pars reticulata, as well as deposits of iron. Our histopathologic findings implicate three possible mechanisms, namely, lipid peroxidation, a deficiency of fatty acid membrane components, and increased cGMP which, either singly or in combination, are responsible for a pathogenesis that is common to the eye and brain in Hallervorden-Spatz syndrome.

PubMed Disclaimer

Similar articles

Cited by

References

    1. Arteriosclerosis. 1984 Jan-Feb;4(1):49-58 - PubMed
    1. Invest Ophthalmol Vis Sci. 1977 Oct;16(10):947-62 - PubMed
    1. Lancet. 1983 Jan 29;1(8318):225-8 - PubMed
    1. Med Lab Sci. 1976 Oct;33(4):281-5 - PubMed
    1. J Bioenerg Biomembr. 1986 Apr;18(2):71-91 - PubMed

Publication types

MeSH terms